Senju Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Senju Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Senju Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Senju Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Senju Pharmaceutical Co Ltd (Senju) develops pharmaceutical products for the care of the five sensory organs: eye, ear, nose, throat and skin. The company categorizes its business into five categories namely Medical drugs, OTC medicines, medical devices and healthcare, veterinary medicines and animal health, and Supplement business .
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company is actively engaged in research and development initiatives focusing on ophthalmic conditions. It focuses on identifying the molecules responsible for ocular disease using advanced information and technologies. Its R&D pipeline includes several products in various stages of development, such as Difluprednate for inflammation associated with ocular surgery and uveitis, which is approved in Russia, and Pranoprofen for inflammation, currently under review in Vietnam. Other pipeline products include SJP-0132 and SJP-0154 for dry eye, SJP-0135 and SJP-0170 for glaucoma, and SJP-0008 for Central Retinal Artery Occlusion, with clinical trials being conducted primarily in Japan and China. The R&D unit of Senju Pharmaceutical Co Ltd includes the Pharmaceutical Research Laboratories, which is responsible for managing the company's research and development activities, as indicated by the involvement of this unit in published research. The company has two research laboratories in Kobe, Japan and in Oregon, the US to produce ophthalmic medicines, based on nucleic acid and protein structures and functions. The Kobe laboratory conducts basic research in the development of ophthalmic medicines. The Oregon laboratory performs basic research on the molecular basis of ocular diseases.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer